KNBIF News Alert Kane Biotech (KNBIF) 0.0400 12/25/2014 07:0

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Kane Biotech (KNBIF) 0.0400 $KNBIF

Kane Biotech Announces Issuance of Common Shares in Payment of Outstanding Interest
Marketwired - Tue Dec 23, 1:28PM CST
Kane Biotech Inc. (TSX VENTURE: KNE) (the "Corporation" announced that on December 19, 2014, it issued 251,392 common shares of the Corporation ("Common Shares" in payment of $12,569.62 in interest owing on the Corporation's $500,000 2 year 10% convertible redeemable unsecured note (the "Note" as at March 18, 2014. Pursuant to the terms of the Note, the Corporation has the option to issue Common Shares in lieu of cash in payment of interest on the Note at a deemed price per share equal to the market price of the Common Shares on the applicable interest payment date, subject to a minimum price of $.05 per share and the approval of the TSX Venture Exchange (the "Exchange" . The approval of the Exchange for the issuance of the Common Shares was obtained by the Corporation on December 23, 2014. The Common Shares issued by the Corporation are restricted from transfer for a period of four months from the date of issuance in accordance with applicable securities laws and TSX Venture Exchange policies.
KNE.VN: 0.040 (unch)

Kane Biotech Announces Second Closing of Private Placement Offering
Marketwired - Wed Dec 17, 10:28AM CST
Kane Biotech Inc. (TSX VENTURE: KNE) (the "Company" or "Kane Biotech" , a biotechnology company engaged in the development of products that prevent and remove microbial biofilms, has completed the second closing of its current private placement offering (the "Offering" with additional aggregate gross proceeds to the Company of $50,000 from the sale of 1,000,000 units ("Units" at a price of $0.05 per Unit. Each Unit is comprised of one common share of the Company (a "Share" and one Share purchase warrant (a "Warrant" . Each Warrant will expire 18 months from the date the Warrant is issued (the "Expiry Date" and will entitle the holder to purchase one Share at a price of $0.06 up to the Expiry Date. The total amount raised by Kane at the first and second closings of the Offering is $1,225,000 from the sale of 24,500,000 Units.
KNE.VN: 0.040 (unch)

Kane Biotech Announces Closing of Private Placement Offering
Marketwired - Tue Dec 09, 7:04AM CST
Kane Biotech Inc. (TSX VENTURE: KNE) (the "Company" or "Kane Biotech" , a biotechnology company engaged in the development of products that prevent and remove microbial biofilms, has closed its previously announced private placement offering (the "Offering" with aggregate gross proceeds to the Company of $1,175,000 from the sale of 23,500,000 units ("Units" at a price of $0.05 per Unit. Each Unit is comprised of one common share of the Company (a "Share" and one Share purchase warrant (a "Warrant" . Each Warrant will expire 18 months from the date the Warrant is issued (the "Expiry Date" and will entitle the holder to purchase one Share at a price of $0.06 up to the Expiry Date.
KNE.VN: 0.040 (unch)

Kane Biotech Announces Grant of Options
Marketwired - Wed Nov 19, 4:11PM CST
Kane Biotech Inc. (TSX VENTURE: KNE), a biotechnology company engaged in the development and commercialization of products that prevent and remove microbial biofilms, announces that the Company has granted an aggregate of 250,000 stock options at an exercise price of $.05 per common share to Mark Nawacki a director of the Company. The options pursuant to the Corporation's stock option plan and are subject to TSX Venture Exchange acceptance. In accordance with securities regulatory requirements, any shares issued pursuant to the exercise of such options will be subject to resale restriction for a period of four months from the date of the grant.
KNE.VN: 0.040 (unch)

Kane Biotech Announces Amendment to Private Placement Offering
Marketwired - Mon Nov 10, 9:02AM CST
Kane Biotech Inc. (TSX VENTURE: KNE) (the "Corporation" today announced an amendment to the terms of the previous announced non-brokered private placement offering of units ("Units" of the Corporation (the "Offering" . The Corporation has determined to amend the terms of the Offering to provide that up to 24,000,000 Units will be offered at a price of $0.05 per Unit for gross proceeds of up to $1,200,000. Each Unit will be comprised of one common share of the Corporation (a "Share" and one Share purchase warrant (a "Warrant" . Each Warrant shall entitle the holder thereof to purchase one Share at a price of $0.06 per Share for a period of 18 months from the date of issuance of the Warrant. All other terms of the Offering shall remain the same.
KNE.VN: 0.040 (unch)

Kane Biotech Appoints Mark Nawacki to the Board of Directors
Marketwired - Wed Oct 08, 7:06AM CDT
Kane Biotech Inc. (TSX VENTURE: KNE), a biotechnology company developing and commercializing products that prevent and remove microbial biofilms announces today the appointment of Mark Nawacki to its board of directors. Mark will be replacing Richard Cherney who is retiring from the board.
KNE.VN: 0.040 (unch), PFE: 31.42 (-0.03)

Kane Biotech Announces Private Placement Offering
Marketwire - Mon Oct 06, 8:31AM CDT
Kane Biotech Inc. (TSX VENTURE: KNE) (the "Corporation" today announced the intention of the Corporation to undertake a non-brokered private placement offering (the "Offering" of up to 20,000,000 units ("Units" at a price of $0.06 per Unit for gross proceeds of up to $1,200,000. Each Unit shall be comprised of one common share of the Corporation (a "Share" and one Share purchase warrant (a "Warrant" . Each Warrant shall entitle the holder thereof to purchase one Share at a price of $0.12 per Share for a period of 12 months from the date of issuance of the Warrant.
KNE.VN: 0.040 (unch)

Kane Biotech Provides Business and Patent Update
Marketwire - Tue Sep 23, 7:03AM CDT
Kane Biotech Inc. (TSX VENTURE: KNE), a biotechnology company engaged in the development and commercialization of products that prevent and remove microbial biofilms, is providing an update to shareholders on the company's business objectives and plans.
KNE.VN: 0.040 (unch)

Kane Biotech Market Activity
Marketwire - Thu Sep 11, 10:58AM CDT
Kane Biotech Inc. (TSX VENTURE: KNE), a biotechnology company engaged in the development and commercialization of products that prevent and remove microbial biofilms wishes to confirm that the Company's management is unaware of any material change in the Company's operations that would account for the recent increase in market activity.
KNE.VN: 0.040 (unch)




Scroll down for more posts ▼

Top 10 Most Recent News Articles

Great Rail Journeys Bets Bigger on Luxury Rail in 2027

Updated Category News Views 107

A $19,995 vacation is not selling a seat on a train; it is selling relief from planning, crowds and compromise. Great Rail Journeys is leaning hard into that proposition for 2027 with two additions to its premium Landmark Collection: a Europe-heavy Orient Express and Rhône cruise pairing, plus a South Africa itinerary built around safari, Victoria Falls and rail-flavored...

Continue Reading
Sogroya Approval Broadens Novo's Pediatric Growth Franchise

Updated Category News Views 75

Seven fewer injections every week is the real headline behind Novo Nordisk's latest FDA clearance, not some flashy efficacy leap. On November 20, 2026, the company said Sogroya, its once-weekly long-acting growth hormone, won approval for children aged 2.5 and older with growth failure associated with Turner syndrome. That matters because treatment can stretch over years,...

Continue Reading
Niron's $1.8B Alabama Bet Carries Big Magnet Stakes

Updated Category News Views 54

A Huge Factory Claim Needs More Than Applause A magnet company just tossed a very large number onto Alabama's economic-development table. Niron Magnetics says it plans a $1.8 billion investment in the state that would create 700 jobs. That is not pocket change, not a ribbon-cutting trinket, and not the sort of announcement investors should breeze past between earnings...

Continue Reading
Allooloo's 100M Calls Test Capital Markets AI Data

Updated Category News Views 138

Forty-one point nine thousand issuers is a lot of financial clutter to keep straight, and Allooloo says its machines are getting called on to do precisely that at industrial scale. The Vancouver-based company reported on November 20 that its capital-markets data products now receive 100 million AI-agent calls a month—roughly 3.4 million daily, or 39 per second. That is...

Continue Reading
Rosalind Franklin University’s $23.8M Scholarship Win

Updated Category News Views 80

Twenty-three million dollars can disappear fast in graduate health education, which is exactly why Rosalind Franklin University’s campaign result deserves more than a polite round of applause. The university’s five-year Empowering Scholars effort closed in June 2026 with $23,836,272 raised, clearing its $20 million target by roughly 19%. In a world where institutions...

Continue Reading
CCAPP Holiday Training Targets Seasonal Recovery Strain

Updated Category News Views 53

December cheer has a nasty habit of hiding the people barely holding themselves together. CCAPP’s upcoming virtual workshop, Hope for the Holidays: Understanding Depression, Stress & Resilience During the Holiday Season, takes that uncomfortable reality seriously rather than treating it like a seasonal footnote. For behavioral health workers supporting people in...

Continue Reading
Rock Gate Buys Aviation Niche Player Blast Deflectors

Updated Category News Views 167

Jet exhaust is not glamorous, but somebody has to keep it from battering everything nearby. Rock Gate Partners’ acquisition of Blast Deflectors, Inc. puts money behind one of those stubbornly unsexy industrial niches where engineering credibility matters far more than a flashy sales pitch. The transaction closed October 16, 2026, and Northborne Partners announced...

Continue Reading
Flair's New Aviation Alliance Offers Options, Not Orders

Updated Category News Views 70

Aircraft shortages have a funny way of turning vague partnerships into very useful insurance policies. Flair Airlines, Phoenix Aviation Capital and Avia Solutions Group announced a Strategic Commercial Cooperation Agreement on Nov. 19, 2026, and the sensible reading is straightforward: the Canadian value carrier wants more ways to solve capacity and operational problems...

Continue Reading
Travel Disruptions Reveal the Value of Human Support

Updated Category News Views 119

Air travel’s ugly little secret surfaced again during the recent ground stop: a reservation is easy, but rescuing a trip is labor-intensive, fast-moving work. Internova Travel Group says its people across Travel Leaders Network, Global Travel Collection and ALTOUR moved quickly as cancellations piled up and travelers were left staring at busted itineraries. That is not...

Continue Reading
Align Wagner Collection Tests Men's Footwear Depth

Updated Category News Views 57

Three pairs of shoes are not a revolution, but they can expose whether a young brand has its footing. Align, established in 2025 by H.H. Brown, is rolling out the Wagner collection for Fall-Winter 2026 with a waterproof boot, a penny loafer and a lace-up oxford. That is a sensible little arsenal, not some overstuffed catalog dreamed up by a marketing committee that has...

Continue Reading

Top 5 Most Recently Viewed Articles

Global Microinsurance Market Expected to Surpass $11 Billion by 2034

Updated Category News Views 137

Growth Trajectory of the Global Microinsurance Market The microinsurance market is witnessing remarkable transformation as consumer demands shift towards financial inclusion, coupled with increasing awareness of the myriad advantages insurance provides. This positive trend is fueled by government initiatives aimed at regulation and expansion of microinsurance offerings,...

Continue Reading
Ormat Technologies Launches Secondary Stock Offering

Updated Category News Views 188

Ormat Technologies Launches Secondary Stock Offering Ormat Technologies, Inc. (NYSE: ORA), renowned for its innovative geothermal and renewable energy solutions, recently announced an exciting development in the investment realm—the initiation of an underwritten secondary offering. This offering encompasses a total of 3,700,000 shares of common stock on behalf of ORIX...

Continue Reading
MongoDB Executive Share Transactions Highlight Growth Potential

Updated Category News Views 132

Insights from MongoDB Executive Share Transactions Cochran Hope F, a director at MongoDB, Inc. (NASDAQ: MDB), recently made notable moves with the company's Class A Common Stock, and these transactions were disclosed in the latest SEC filings. This activity has attracted attention from investors. In September, the director sold 1,174 shares at $224.38 each, which brought...

Continue Reading
Essential Guidance for Navigating Hurricane Travel Risks

Updated Category News Views 69

Essential Guidance for Navigating Hurricane Travel Risks Hurricane season brings with it the potential for severe weather that can disrupt travel plans and lead to significant financial losses. As storms like Hurricane Helene have shown, the impact can be widespread, devastating homes and infrastructure, particularly in the southeastern regions. During these turbulent...

Continue Reading
Ascend Performance Materials Launches High-Purity Production

Updated Category News Views 279

Ascend Performance Materials Starts High-Purity Acrylonitrile Production Ascend Performance Materials has recently announced an exciting new phase in its production capabilities. The company is now producing high-purity acrylonitrile at its Chocolate Bayou facility. This advancement comes after the successful installation and commissioning of state-of-the-art purification...

Continue Reading